These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26746572)

  • 1. Aptamers as radiopharmaceuticals for nuclear imaging and therapy.
    Gijs M; Aerts A; Impens N; Baatout S; Luxen A
    Nucl Med Biol; 2016 Apr; 43(4):253-71. PubMed ID: 26746572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of radiolabeled aptamers in diagnostic nuclear medicine: A new class of targeted radiopharmaceuticals.
    Farzin L; Shamsipur M; Moassesi ME; Sheibani S
    Bioorg Med Chem; 2019 Jun; 27(12):2282-2291. PubMed ID: 30502114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: aptamers as novel radiopharmaceuticals: their applications and future prospects in diagnosis and therapy.
    Missailidis S; Perkins A
    Cancer Biother Radiopharm; 2007 Aug; 22(4):453-68. PubMed ID: 17803440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid-based aptamers: applications, development and clinical trials.
    Kanwar JR; Roy K; Maremanda NG; Subramanian K; Veedu RN; Bawa R; Kanwar RK
    Curr Med Chem; 2015; 22(21):2539-57. PubMed ID: 25723512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamers: A promising chemical antibody for cancer therapy.
    Zhou G; Wilson G; Hebbard L; Duan W; Liddle C; George J; Qiao L
    Oncotarget; 2016 Mar; 7(12):13446-63. PubMed ID: 26863567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabelled aptamers for tumour imaging and therapy.
    Perkins AC; Missailidis S
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):292-6. PubMed ID: 17464274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer cells with nucleic acid aptamers.
    Cerchia L; de Franciscis V
    Trends Biotechnol; 2010 Oct; 28(10):517-25. PubMed ID: 20719399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.
    Adachi T; Nakamura Y
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.
    Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G
    Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid aptamers targeting cell-surface proteins.
    Dua P; Kim S; Lee DK
    Methods; 2011 Jun; 54(2):215-25. PubMed ID: 21300154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid aptamers against biotoxins: a new paradigm toward the treatment and diagnostic approach.
    Lauridsen LH; Veedu RN
    Nucleic Acid Ther; 2012 Dec; 22(6):371-9. PubMed ID: 23113767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers and their applications in nanomedicine.
    Sun H; Zu Y
    Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aptamers in clinical diagnostics].
    Szpechciński A; Grzanka A
    Postepy Biochem; 2006; 52(3):260-70. PubMed ID: 17201061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer.
    Musumeci D; Montesarchio D
    Pharmacol Ther; 2012 Nov; 136(2):202-15. PubMed ID: 22850531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Aptamers Targeting Immune System.
    Hu PP
    Inflammation; 2017 Feb; 40(1):295-302. PubMed ID: 27590235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers: active targeting ligands for cancer diagnosis and therapy.
    Wu X; Chen J; Wu M; Zhao JX
    Theranostics; 2015; 5(4):322-44. PubMed ID: 25699094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamers: from bench side research towards patented molecules with therapeutic applications.
    Majumder P; Gomes KN; Ulrich H
    Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.